Your health care provider will use your age and the results of the blood test and ultrasound exam to gauge your risk of carrying a baby with Down syndrome or trisomy 18. Other factors — such as a prior Down syndrome pregnancy — also might affect your risk.
First trimester screening results are given as positive or negative and also as a probability, such as a 1 in 250 risk of carrying a baby with Down syndrome.
First trimester screening correctly identifies about 85 percent of women who are carrying a baby with Down syndrome. About 5 percent of women have a false-positive result, meaning that the test result is positive but the baby doesn't actually have Down syndrome.
When you consider your test results, remember that first trimester screening only indicates your overall risk of carrying a baby with Down syndrome or trisomy 18. A low-risk result doesn't guarantee that your baby won't have one of these conditions. Likewise, a high-risk result doesn't guarantee that your baby will be born with one of these conditions.
After a positive test result, your health care provider and genetics professional will discuss your options, including additional testing. For example:
- Prenatal cell-free DNA (cfDNA) screening. This is a sophisticated blood test that examines fetal DNA in the maternal bloodstream to determine whether your baby is at risk of Down syndrome, extra sequences of chromosome 13 (trisomy 13) or extra sequences of chromosome 18 (trisomy 18). Some forms of cfDNA screening also screen for other chromosome problems and also provide information about fetal gender. A normal result might eliminate the need for a more-invasive prenatal diagnostic test.
- Chorionic villus sampling (CVS). CVS can be used to diagnose chromosomal conditions, such as Down syndrome. During CVS, which is usually done during the first trimester, a sample of tissue from the placenta is removed for testing. CVS poses a small risk of miscarriage.
- Amniocentesis. Amniocentesis can be used to diagnose both chromosomal conditions, such as Down syndrome, and neural tube defects, such as spina bifida. During amniocentesis, which is usually done during the second trimester, a sample of amniotic fluid is removed from the uterus for testing. Like CVS, amniocentesis poses a small risk of miscarriage.
Your health care provider or a genetic counselor will help you understand your test results and what the results mean for your pregnancy.
Oct. 09, 2015
- Messerlian GM, et al. First trimester combined and integrated tests for screening for Down syndrome and trisomy 18. http://www.uptodate.com/home. Accessed Aug. 12, 2015.
- Benacerraf BR. Sonographic findings associated with fetal aneuploidy. http://www.uptodate.com/home. Accessed Aug. 12, 2015.
- Messerlian GM, et al. Laboratory issues related to maternal serum screening for Down syndrome. http://www.uptodate.com/home. Accessed Aug. 6, 2015.
- Frequently asked questions. Diagnostic tests for birth defects FAQ164. American College of Obstetricians and Gynecologists. http://www.acog.org/Patients/FAQs/Diagnostic-Tests-for-Birth-Defects. Accessed Aug. 12, 2015.
- Messerlian GM, et al. Down syndrome: Overview of prenatal screening. http://www.uptodate.com/home. Accessed Aug. 6, 2015.
- Ostermaier KK. Management of Down syndrome. http://www.uptodate.com/home. Accessed Aug. 12, 2015.
- Cunningham FG, et al. Prenatal diagnosis. In: Williams Obstetrics. 24th ed. New York, N.Y.: The McGraw-Hill Companies; 2014. http://www.accessmedicine.com. Accessed Aug. 3, 2015.
- Fischbach FT, et al. Prenatal diagnosis and tests of fetal well-being. In: A Manual of Laboratory and Diagnostic Tests. 9th ed. Philadelphia, Pa.: Lippincott Williams & Wilkins; 2015.
- Beckman CRB, et al. Genetics and genetic disorders in obstetrics and gynecology. In: Obstetrics and Gynecology. 7th ed. Baltimore, Md.: Lippincott Williams & Wilkins; 2014.
- AskMayoExpert. Prenatal testing and diagnostic screening. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
- Wolfberg A, et al. Noninvasive prenatal testing using cell-free nucleic acids in maternal blood. http://www.uptodate.com/home. Accessed Aug. 7, 2015.
- American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins — Obstetrics. ACOG Practice Bulletin No. 77: Screening for fetal chromosomal abnormalities. Obstetrics & Gynecology. 2007;109:217. Reaffirmed 2013.
- American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 640: Cell-free screening for fetal aneuploidy. Obstetrics & Gynecology. 2015;126:e31.